With the analysis among 1,042 patents, we discovered top 193 key players by total patent application. Nanjing Qizhen Genetic Engineering Co., Ltd., CRISPR Therapeutics AG, Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 17.08% of the total patent filing.
Nanjing Qizhen Genetic Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 67
Massachusetts, United States
Patent: 64
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 47
Astellas Institute for Regenerative Medicine
Massachusetts, United States
Patent: 24
California, United States
Patent: 23
California, United States
Patent: 22
California, United States
Patent: 22
Alabama, United States
Patent: 20
California, United States
Patent: 16
Mitsubishi Electric Corp.
Tokyo-to, Japan
Patent: 14
With the analysis among 20 patents, we discovered top 9 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Eligo Bioscience SA, Luca Science, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Lombardia, Italy
Patent: 3
Wisconsin, United States
Patent: 1
Massachusetts, United States
Patent: 1
Georgia, United States
Patent: 1
California, United States
Patent: 1
Kanagawa-ken, Japan
Patent: 1
With the analysis among related 436 patents applied in the last 5 years. We discover 103 most active companies in this area. The fast-growing Nanjing Qizhen Genetic Engineering Co., Ltd., CRISPR Therapeutics AG, The University of North Carolina at Chapel Hill take 35.32% of patent filing during this period.
Nanjing Qizhen Genetic Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 67
Massachusetts, United States
Patent: 64
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 23
H. Lee Moffitt Cancer Center & Research Institute, Inc.
California, United States
Patent: 13
Ohio State Innovation Foundation
Ohio, United States
Patent: 11
Wisconsin, United States
Patent: 8
Alabama, United States
Patent: 8
California, United States
Patent: 7
With the analysis among related 436 patents in last 5 years, we discover 66 new entrants. Nanjing Qizhen Genetic Engineering Co., Ltd., CRISPR Therapeutics AG, H. Lee Moffitt Cancer Center & Research Institute, Inc. are the most active new entrants in this area.
Nanjing Qizhen Genetic Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 67
Massachusetts, United States
Patent: 64
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Ohio State Innovation Foundation
Ohio, United States
Patent: 11
Wisconsin, United States
Patent: 8
California, United States
Patent: 6
University Health Network
Ningbo Yisai Teng Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 4
With the analysis among 697 patents, we discovered top 66 universities and scientific research institutions by total patent application. University of Massachusetts, The University of North Carolina at Chapel Hill, Northwest A&F University are dominant in this area. They take 20.23% of the total patent filing.
University of Massachusetts
Massachusetts, United States
Patent: 49
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 30
Shaanxi Sheng, China
Patent: 19
Connecticut, United States
Patent: 15
The Johns Hopkins University
China Agricultural University
Beijing Shi, China
Patent: 11
University of Connecticut
Connecticut, United States
Patent: 10
Victoria, Australia
Patent: 10
Washington, United States
Patent: 9